تولید ژلاتین کپسول ایران
دکپسول | Stocks - Iran Fara Bourse (IFB)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 192,300 3.00
Close Price: 191,900
Cash Flow
AGM
Interim
2026/05/24 Fiscal Year 2026/03/2012 Month / Audited | 2026/05/19 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 1.208 Trillion | 1.208 Trillion | |
Income Taxes Paid | -617.28 Billion | -617.28 Billion | |
Net Cash Flow from Operating Activities | 590.334 Billion | 590.334 Billion | |
Proceeds from Sale of Property, Plant and Equipment | 11.326 Billion | 11.326 Billion | |
Purchases of Property, Plant and Equipment | -644.609 Billion | -644.609 Billion | |
Purchases of Intangible Assets | -1.45 Billion | -1.45 Billion | |
Cash Paid to Acquire Long-Term Investments | -59 Million | -59 Million | |
Cash Received from Income on Other Investments | 37.784 Billion | 37.784 Billion | |
Net Cash Flow from Investing Activities | -597.008 Billion | -597.008 Billion | |
Net Cash Flow before Financing Activities | -6.674 Billion | -6.674 Billion | |
Cash Received from Borrowings | 3.526 Trillion | 3.526 Trillion | |
Repayments of Borrowings (Principal) | -1.605 Trillion | -1.605 Trillion | |
Interest Paid on Borrowings | -267.479 Billion | -267.479 Billion | |
Dividends Paid | -2.58 Trillion | -2.58 Trillion | |
Net Cash Flow from Financing Activities | -926.742 Billion | -926.743 Billion | |
Net Increase (Decrease) in Cash | -933.416 Billion | -933.417 Billion | |
Cash at Beginning of Period | 2.137 Trillion | 2.137 Trillion | |
Effect of Exchange Rate Changes | 16.642 Billion | 16.643 Billion | |
Cash at End of Period | 2.154 Trillion | 2.154 Trillion |